Literature DB >> 35958484

Promoting the formation of Pi-stacking interaction to improve CTL cells activation between modified peptide and HLA.

Ying Zhu1, Chang-Xin Huang2, Le Zhang3, Ze-Fang Wang4, Dong-Li Zhao3, Fei Ding2, Si-Yu Zhang2, Yong-Qiang Li2, Ling-Zhi Chen5.   

Abstract

OBJECTIVE: This study aims to investigate the use of single residue substitution to promote the formation of pi-stacking interactions between peptides and Human leukocyte antigen (HLA)-A*2402 molecules to improve the affinity of peptides and HLA molecules, as well as the level of cytotoxic T lymphocyte (CTL) cells activated by peptides-HLA (p-HLA) complex.
METHODS: Molecular docking and molecular dynamics simulation were used to simulate and analyze the interactions and binding free energies between HLA-A*2402-restricted antigen peptides and HLA molecules, before and after the single residue substitution. HLA-A*2402 restricted antigen peptides before and after the single residue replacement were loaded into dendritic cells (DCs) in vitro, and further Enzyme-Linked ImmunoSpot (ELispot) test was carried out to evaluate the effect of modified antigen peptides on the immune activation of CTL cells. RESULT: After replacing the antigen peptides with a single residue, some of them could promote the formation of pi-stacking interaction. The binding free energy between the modified antigen peptides and HLA-A*2402, as well as the level of immune activation of CTL cells were mostly higher than before, especially after the replacement of the 9th residue of the polypeptide, such as C9F and C9W. There was a significant negative correlation between the level of activated CTL cells by modified antigen peptides and the total interaction amount of hydrogen bonds and salt bridges.
CONCLUSION: Promoting the formation of pi-stacking interaction between antigen peptides and HLA-A*2402 molecules could increase the total binding free energy of p-HLA complex and the level of CTL cells activation. In addition, the amount of hydrogen bonds and salt bridges between peptides and HLA could reduce the level of immune activation. All the characteristics above can improve the immunogenicities of the weak antigens. AJTR
Copyright © 2022.

Entities:  

Keywords:  Residue substitution; T cell activation; molecular dynamics simulation; pi-stacking (π-stacking)

Year:  2022        PMID: 35958484      PMCID: PMC9360904     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  24 in total

Review 1.  T-cell development and the CD4-CD8 lineage decision.

Authors:  Ronald N Germain
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing.

Authors:  Timothy J O'Donnell; Alex Rubinsteyn; Uri Laserson
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

3.  A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction.

Authors:  Shutao Mei; Fuyi Li; André Leier; Tatiana T Marquez-Lago; Kailin Giam; Nathan P Croft; Tatsuya Akutsu; A Ian Smith; Jian Li; Jamie Rossjohn; Anthony W Purcell; Jiangning Song
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

Review 4.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

5.  Combining Three-Dimensional Modeling with Artificial Intelligence to Increase Specificity and Precision in Peptide-MHC Binding Predictions.

Authors:  Michelle P Aranha; Yead S M Jewel; Robert A Beckman; Louis M Weiner; Julie C Mitchell; Jerry M Parks; Jeremy C Smith
Journal:  J Immunol       Date:  2020-09-02       Impact factor: 5.422

6.  Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer.

Authors:  Andrew J Rech; David Balli; Alejandro Mantero; Hemant Ishwaran; Katherine L Nathanson; Ben Z Stanger; Robert H Vonderheide
Journal:  Cancer Immunol Res       Date:  2018-01-16       Impact factor: 11.151

7.  Related parameters of affinity and stability prediction of HLA-A*2402 restricted antigen peptides based on molecular docking.

Authors:  Changxin Huang; Jianfeng Chen; Fei Ding; Lili Yang; Siyu Zhang; Xuechun Wang; Yanfei Shi; Ying Zhu
Journal:  Ann Transl Med       Date:  2021-04

8.  Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.

Authors:  Kevin Michael Boehm; Bhavneet Bhinder; Vijay Joseph Raja; Noah Dephoure; Olivier Elemento
Journal:  BMC Bioinformatics       Date:  2019-01-05       Impact factor: 3.169

Review 9.  Antigen processing and presentation in cancer immunotherapy.

Authors:  Maxwell Y Lee; Jun W Jeon; Cem Sievers; Clint T Allen
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

10.  Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development.

Authors:  Neeha Zaidi; Mariya Soban; Fangluo Chen; Heather Kinkead; Jocelyn Mathew; Mark Yarchoan; Todd D Armstrong; Shozeb Haider; Elizabeth M Jaffee
Journal:  JCI Insight       Date:  2020-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.